Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services
January 18 2022 - 4:15PM
Business Wire
Phreesia is pleased to announce that the healthcare marketing
industry trade publication PM360 has named PatientInsights,
Phreesia Life Sciences’ market research platform, to its list of
2021 Most Innovative Services.
Over the last decade, PM360’s annual Innovations Issue has
spotlighted the pharma industry’s most innovative companies,
products, strategies, services and more. PatientInsights was one of
52 overall honorees, chosen from hundreds of submissions, and one
of just eight services to be recognized for “compelling offerings
that help the industry tackle new challenges.”
PM360 highlighted PatientInsights’ ability to reach patients
with targeted custom surveys just before their doctors’
appointments, when they’re preparing to share their opinions and
experiences about their health conditions or treatment. This
process both ensures participants are real patients and produces
more reliable data.
“We’re honored to receive this recognition for PatientInsights
and the innovation it has brought to pharma market research,” Joyce
Wang, Associate Research Director, Life Sciences, said. “By
identifying ideal respondents based on their chart history, we’re
thrilled to be able help our partners engage hard-to-reach patient
groups and uncover key motivations, concerns and questions that
drive patient health behaviors.”
On top of helping surveys reach clinically relevant audiences,
PatientInsights’ electronic health record integrations enable the
platform to bypass basic screening and demographic questions, PM360
noted. This winnowing process cuts surveys from the typical 30 to
40 questions down to about 15, resulting in more patient-friendly
surveys that feature better, smarter questions and generate higher
completion rates.
“At Phreesia Life Sciences, patient centricity is at the heart
of everything we do,” David Linetsky, SVP of Life Sciences, said.
“We’re very proud that PatientInsights not only helps companies
conduct fast, actionable market research, but also lets patients
quickly and easily share their opinions to help shape the future of
their care. Every interaction with a patient is an opportunity to
drive a positive outcome and to learn something that will help
drive future outcomes.”
About Phreesia Life Sciences
Phreesia empowers life sciences companies to connect
meaningfully with clinically relevant patients, delivering targeted
health content in a one-to-one setting. Our PatientConnect offering
identifies and motivates the right patients to initiate meaningful
brand conversations, and our PatientInsights product enables our
clients to better understand their target patient populations.
Phreesia meets patients where they are, both virtually and
in-person, and reaches them at multiple touchpoints throughout
their healthcare journey. To learn more about Phreesia Life
Sciences, visit lifesciences.phreesia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220118006059/en/
Media Contact: Carly Helfand
chelfand@phreesia.com 332-910-6768
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Oct 2023 to Oct 2024